Overview

To Demonstrate the Relative Bioavailability of Fluoxetine Hydrochloride Capsules, 40 mg

Status:
Completed
Trial end date:
2001-04-01
Target enrollment:
Participant gender:
Summary
To demonstrate the relative bioavailability of fluoxetine hydrochloride capsules, 40 mg.
Phase:
Phase 1
Details
Lead Sponsor:
Sandoz
Treatments:
Fluoxetine